Tuesday 25 July 2017

Hyperbaric Oxygen Therapy (HBOT) Devices Market Size ,Share and Forecast uoto 2025

Hyperbaric oxygen therapy (HBOT) devices are used to deliver 100% pure oxygen to tissues in the body under high atmospheric pressure. During HBOT, the pressure is increased to three times the normal atmospheric pressure, creating high amount of partial pressure of oxygen. Under normal conditions, one atmosphere absolute are subjected to be around 14.7 pounds per square inch of pressure and the air we normally breathe is composed of 21% oxygen and 79% nitrogen. Breathing in 100% oxygen, the body is exposed to rise in atmospheric pressure, the oxygen molecules become condensed and this allows to breathe a higher amount of partial pressure of oxygen, where in turn oxygen dissolves in the plasma around 10 to 15 times greater than normal. This super-saturation of oxygen in the body’s tissues promotes the increase in capillary growth, increase in white blood cell (WBC) activity, new tissues development, increase oxygen tension in hypoxic areas, reduction in the size of gas bubbles and numerous other physiological effects.
HBOT devices play a vital role in the field of medicine, these devices help in the treatment of many diseases such as asthma, HIV/AIDS, bell’s palsy, Parkinson’s disease, spinal cord injuries, hepatitis, migraines, multiple sclerosis, stroke and sport injuries. Moreover, HBOT devices have Food and Drug Administration (FDA) approval for treating decompression sickness, thermal, necrotizing soft tissues infection and burn injury. HBOT devices are also used in the off-label (means the medication is not specified in the FDA's approved packaging label) medical induction treatment such as brain injuries and cancer. Such high preference from the patients and physicians for HBOT in medical field has powered growth in the HBOT devices market. The market is expected to rise in the forecast period, especially across the North America, Europe and Asia-Pacific region.
Hyperbaric oxygen therapy (HBOT) devices market by taxonomy
Hyperbaric Oxygen Therapy Devices Market, by Product Type:
  • Monoplace HBOT Devices
  • Topical HBOT Devices
  • Multiplace HBOT Devices
by Application:
  • Wound Healing
  • Decompression Sickness
  • Infection Treatment
  • Gas Embolism
  • Others
by Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
Increase in number of wound healing treatment and cosmetic procedures is expected to support the growth of hyperbaric oxygen devices market
The growth in usage of hyperbaric oxygen therapy in healing of wound and cosmetic procedure is one of the factor to rise in demand in forecast period and also the rise in healthcare costs, increase in prevalence of diseases such as asthma, diabetes, and growth rate in aging population are some of the factors that can be accounted for the largest market share. Asia Pacific market is expected to grow in the forecast period due to the increase in income, growth in medical tourism industry, and rise in public awareness benefits HBOT devices.
People who are suffering from diabetes are at increased risk for a wound development. According to the Center for Disease Control and Prevention (CDC) in the U.S., it was diagnosed that around 21.0 million people suffered from diabetes in 2014. The U.S. is expected to be the growth engine of the global HBOT market through the forecast period. This is mainly attributed to increase in incidence rate of diabetes, and rising chronic disease and acute wounds and simultaneously growth in treatment rate due to the developed healthcare technology, healthcare expenditure by the government and high disposable income are some of the factors that are expected to support the market in future near.
As per The American Society of Plastic Surgeons (ASPS) around 15.9 million minimally invasive cosmetic procedures were performed in 2014-2015 in the U.S. Moreover, increasing number of metrosexual men is in turn expected to create a highly conducive environment for growth of the HBOT market.
Key players in the market:
  • Fink Engineering
  • HAUX-LIFE-SUPPORT
  • Gulf Coast Hyperbarics, Inc.
  • IHC Hytech B.V. (Royal IHC)
  • HEARMEC; Hyperbaric
  • Sechrist Industries, Inc.
  • OxyHeal International
  • Haux-Life-Support GmbH
  • HYPERBARIC S.A.C.
  • Hyperbaric Technology (HyTech) B.V.
  • Sands Hyperbaric Corporation
  • SOS Medical Group Ltd.
  • Hearmec Co., Ltd. and Fink Engineering Pty. Ltd.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Autoimmune Disease Diagnostics Market Size ,Share and Forecast upto 2025

The immune system of human body recognize some invaders such as bacteria, viruses, and external chemicals and attacks those to protect the body. However, sometimes the immune system attacks the healthy cells of body by considering them as foreign cells. Such a condition is called autoimmune disease. The autoimmune disease causes abnormal organ growth and changes in organ function. The genes of an individual with environmental exposure might be the major reason for autoimmune disease development. Some of the common autoimmune diseases among over 80 types of autoimmune diseases are type 1 diabetes, systemic lupus erythematosus, inflammatory bowel disease, rheumatoid arthritis. The curing therapy for autoimmune diseases is not yet available only relieving treatments are available for this diseases. Diagnosis of the autoimmune diseases can be done by the tests which involves antinuclear antibody test, antibody test, complete blood counts and some others.
Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/419
The growing incidences of autoimmune diseases and government initiatives to boost the autoimmune disease diagnostics market
According to American Autoimmune Related Disease Association (AARDA), in 2016, around 50 million people suffered from autoimmune diseases in the U.S. with 75% being women. Increasing incidence of autoimmune diseases, rising public awareness and government initiatives taken to spend the budget on diagnosis and care services for autoimmune diseases, are some of the factors which are driving the autoimmune disease diagnostics market. Many of the organizations and governments are funding the research and development program for autoimmune diseases, this will help to launch the new products in the market and definitely help in the growth of autoimmune disease diagnostics industry. For instance, the discovery of novel biomarkers, which has proven to be significant to improve the diagnosis of autoimmune diseases is also one of the major factor driving the autoimmune diseases diagnostic market.
Despite of all the driving factors for the autoimmune disease diagnostics market there are some restraints which slowing down the market such as, high rate of false results, slow turnaround time for test results and lack of experience and education of laboratory personnel in the diagnostics of certain autoimmune diseases.
Aging population and technological advancements in diagnosis of rheumatoid arthritis will be the cause of growth for rheumatoid arthritis segment
The global autoimmune disease diagnostic market are segmented on the basis of disease type, test type, end user and geography
On the basis of disease type, the autoimmune disease diagnostic market is segmented into:
  • Systemic Autoimmune Disease diagnostics
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Systemic Lupus Erythematosus
  • Some Others
  • Localized autoimmune disease diagnostics
  • Multiple Sclerosis
  • Type 1 diabetes
  • Hashimoto’s thyroiditis
  • Idiopathic Thrombocytopenic purpura
The high patient awareness level and large procedure volumes are the reasons that localized autoimmune disease diagnostics is dominating the overall market. Though the initiatives taken by government for patients suffering from rheumatoid arthritis and systemic lupus erythematosus will aid in the growth of systemic autoimmune disease diagnostics segment.
On the basis of test type, the global autoimmune disease diagnostic market is segmented into:
  • Antinuclear Antibody Tests
  • Autoantibody Tests
  • Complete Blood Count
  • C-reactive Protein
  • Others
On the basis of end user, the global autoimmune disease diagnostics market is segmented into
  • Hospitals
  • Diagnostics Centers
  • Research Laboratories
The technological advancements in the North America region driving the autoimmune disease diagnostics market
The regional segmentation of autoimmune disease diagnostics market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Africa and rest of the world. North America is of the largest revenue contributor in the global autoimmune disease diagnostics industry. This is mainly attributed to rising incidence of some of the common autoimmune diseases like rheumatoid arthritis and type1 diabetes. The increase in funding by government and private sector, increasing regulatory scenario monitored by World Health Organization (WHO), and technological advancements are some of the factors which are driving growth of the autoimmune disease diagnostics market in the North America region. Asia Pacific is projected to be a fast emerging region in the global autoimmune disease diagnostic market.
The introduction of novel biomarkers in the market will aid in the growth of autoimmune disease diagnostic market
The key players operating the autoimmune disease diagnostics market are Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Euroimmun, Inova Diagnostics, Roche Diagnostics, Siemens Healthcare, A. Menarini Diagnostics, Adaptive Biotechnologies, AESKU Diagnostics, and many others. The government agencies of various countries are increasing their healthcare spending to provide better health care services, and the introduction of novel biomarkers in the research area, owing for ample opportunity for the key players, which in-turn will boost the autoimmune diseases diagnostic market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Antibody Drug Conjugates Market Size , Share and Forecast upto 2024

Antibody drug conjugate is a significant class of highly potent bio drugs envisioned as a broad therapy for treatment of cancer. Unlike chemotherapy, antibody drug conjugate are proposed to mark and kill only cancer cells. Antibody drug conjugates are compound molecules that comprise antibodies linked to a biologically active cytotoxic drug.
By uniting the exclusive targeting capacities of mAB with anti-cancer drugs, ADCs allow for subtle judgment between healthy and diseased tissue. This entails that the antibody drug conjugates kill only cancer cells and ensure that other dynamic cells are less severely affected. This exceptional phenomenon of killing only cancer cells increase the importance of use of ADCs, which would indirectly boost growth of the global antibody drug conjugates market.
Commercialization of 7-10 ADCs in the following decade, would lead to revenue to surge to over US$ 10 billion over the forecast period of market
In terms of marketing, three antibody drug conjugates have received regulatory approval. The U.S. FDA approved one of the ADC in 2001 manufactured and developed by Pfizer/Wyeth, to treat acute myelogenous leukemia. The drug was subsequently withdrawn in June 2010, leaving only two antibody drug conjugates in the market. The two drugs marketed for ADCs are Brentuximab vedotin and Trastuzumab emtansine, developed and manufactured by Seattle Genetics and Millennium/Takeda and Genentech and Roche, respectively. Around 45 antibody drug conjugates molecules are under clinical trials, with the preclinical pipeline expanding at a high rate. Of all the 45 molecules, around 25% are under Phase II or Phase III of development. Frequently used cytotoxins for antibody drug conjugates under trials include auristatin, calicheamicin, maytansine and duocarmycin. Auristatin is the dominant compound accounting for over 50% of antibody drug conjugates in clinical development. Roche has 10 compounds under clinical trials, and this is the most developed pipeline of antibody drug conjugates. Globally, 70%-80% of antibody drug conjugates manufacturing is currently outsourced. There are limited number of contract manufacturers that have high-end manufacturing equipment for development of cytotoxins.
Antibody drug conjugates market is still in its infancy, with two approved ADCs to propel the market to two digit billion dollar mark by 2020
The global antibody drug conjugates market is segmented on the basis of drug and geography. On the basis of drug, the market is divided into Adcetris and Kadcyla.
Major pharmaceutical company opt for contract manufacturer for development and manufacture of antibody drug conjugates
Regional segmentation of the antibody drug conjugates market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Europe accounts for the largest share in the global market mainly due to presence of many contract manufacturing companies with advanced manufacturing equipment. Lonza is one of the top contract manufacturing companies in Europe, which has operations across France and Germany, with its headquarters in Switzerland. One of the facilities operated by the company is a deck to chemical manufacturing capabilities and develop peptides, small molecule active pharmaceutical ingredients, highly potent active pharmaceutical ingredients, cytotoxics agents, antibody drug conjugates, and microbial products. The company also offer proficiency in chemical, pharmaceutical, agrochemical and food industries by providing clients with yields such as high-class active substances, organic chemicals and intermediates.
Large number of clinical trial molecules in pipeline to boost growth of antibody drug conjugates market
Key players operating the antibody drug conjugates market include Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, and Progenics Pharmaceuticals. Major companies in the antibody drug conjugates industry are constantly working on research and development, as the market is largely untapped and offer highly lucrative growth opportunities. For instance, there are only two antibody drug conjugates available worldwide that are used to treat cancer, and there are over 40 molecules under clinical trials. Considering the alarmingly high incidence rate of cancer across the globe, the antibody conjugates market is expected to ride on a wave of positive growth in the foreseeable future.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Monday 24 July 2017

Cryptococcosis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Cryptococcosis or cryptococcal disease is a fungal disease, which in severe cases can be fatal. It is caused by either Cryptococcus neoformans or Cryptococcus gattii. Cryptococcosis is said to be acquired by inhaling contagious propagule from surroundings. Even though the accurate character of the contagious propagule is not known, the primary theory is the basidiospore produced in the course of sexual or asexual reproduction is the cause. Cryptococcosis disease symptoms include fatigue, fever, headache, blurred vision, dry cough, and confusion. Symptoms onset is often subacute, worsening progressively over more than a few weeks. The two key complications of the disease are meningitis (brain infection) and pulmonary infection or lung infection. The occurrence of cryptococcosis is increasing over the years for various reasons, such as increase in prevalence of AIDS as well as extended use of immunosuppressive drugs. These factors are likely to propel the growth of the overall cryptococcosis treatment market in the near future.
According to a report by National Centre for Biotechnology Information, illnesses due to Cryptococcus fungi occur on a global scale and in an extensive range of hosts, starting from patients who are strictly immunosuppressed to patients with normal immune systems. The Centers for Disease Control and Prevention (CDC) states that around 1 million cryptococcosis cases arise throughout the globe, and it is anticipated that annually, the number of deaths associated with cryptococcosis is around 650,000. Most of the cases are reported among amongst patients with complex HIV disease. However, incidence rate is high amongst the recipients of solid organ transplant and patients getting exogenous immunosuppression. Cryptococcus occurs in those with acquired and innate immunodeficiency as well.
As the AIDS population is rising at a startling rate, the likelihood of occurrence of the disease is rising proportionately. Since cryptococcosis disease is communicable in nature, and it gets transmitted from one affected person to the next, persons suffering from the disease are expected to rise in the near future. Therefore, the cryptococcosis treatment market will also show a considerable growth.
Cryptococcosis Treatment Market Taxonomy
On the basis of type of treatment, global cryptococcosis treatment market is classified into:
    • Amphotericin B
    • Flucytosine
    • Fluconazole
    • Others
Rising prevalence of chronic diseases to fuel cryptococcosis treatment market growth
The major factor working for the increase of the worldwide cryptococcosis treatment market is the rising count of people being contaminated by the disease. As per UNAIDS, there is an estimated 36.7 million cases of AIDS in the world at the end of the year 2015. Rise in the prevalence of diseases such as AIDS will further amplify the demand for the cryptococcosis treatment. Cryptococcosis was classified as a rarely happening illness; however, now the disease is seen to be rising across the globe. Several governments are vastly interested in eliminating the disease altogether from their respective nations. The efforts put in by governments of various regions are encouraging the players in the global market to increase their overall spend on research and development activities, in order to get superior treatment alternatives. This will further aid the global market of cryptococcosis treatment to increase at a steady pace.
Increasing prevalence of cryptococcosis in Sub-Saharan Africa will drive the overall cryptococcosis treatment market growth
According to CDC, in 2009, there were an estimated 720,000 cases of HIV related cryptococcosis in the Sub-Saharan Africa, which is about three times the prevalence of the disease in all other parts of the world, combined. It is believed that the disease kills more people in this region than tuberculosis. Moreover, CDC also states that cryptococcosis is the fourth most fatal disease in the region. It is estimated to cause about 504,000 deaths per year. The occurrence of cryptococcosis in the region is growing at an alarming rate; hence, the market in this region is expected to grow at a significant rate over the forecast period.
Some of the major companies operating in the global cryptococcosis treatment market are Bristol-Myers Squibb Company, Sigmapharm Laboratories LLC, Janssen Biotech, Inc. (Johnson & Johnson), Novartis AG, Abbott Laboratories, Valeant Pharmaceuticals, Inc., Pfizer, Inc., and Glenmark Pharmaceuticals.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Medicinal Cannabis Market- Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

Medicinal cannabis market Overview:
Medicinal cannabis, also known as medicinal marijuana, is used either to treat disease or improve symptoms. Cannabis has been considered to be a major source of drug addiction. Extract from the dried flower bud part of the plant called as Marijuana has certain medicinal properties. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are being used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.
Medicinal Cannabis Market Dynamics
However, the debate still continues regarding the approval, safety and usage of cannabis (marijuana) for medicinal purpose, due to differences in the laws pertaining to this smoked drug. Hence, studies are conducted extensively to establish the safety aspect of this drug. Various states in the U.S. have already legalized cannabis (marijuana) for medicinal purposes. Scientific research of chemicals in the cannabis plant for its potential medicinal use has led to a shift in its demand purpose. Regulatory clearance has played a major role in the growth of medicinal cannabis market.
Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/40
Other names of Cannabis- grass, pot, dope, Mary Jane, hooch, weed, hash, joints, brew, reefers, cones, smoke, mull, buddha, ganga, hydro, yarndi, heads, and green.
The U.S. FDA has approved two medications, Marinol and Syndros, which contain dronabinol in pill form. However, the FDA has not approved the marijuana plant as a medicine. The medicinal cannabis (marijuana) is administered in either of the ways – liquid extract, vaporized form, smoked or solid form.
Prevalent Scenario in the Medicinal Cannabis Market
According to the Medical Marijuana, Inc., the estimated size of the legal marijuana industry in the U.S. is US$ 7.1 billion in 2016. This is an increase of 25% Y-o-Y. As of 2016, 28 states in the U.S. have legalized marijuana for medicinal purpose with some more gearing up for votes on the recreational use of marijuana. California, Nevada, Maine, and Massachusetts states in November 2016, voted to legalize the recreational use of marijuana. The accelerated pace of legalization of cannabis (marijuana) in the U.S. has attracted the attention of global investors in the medicinal cannabis market. However, lack of formulation of a comprehensive law pertaining to medicinal marijuana in some states inhibits patient access to the drug.
Important role of Regulatory Authorities in the Medicinal Cannabis Market Trends
According to the United Nations, marijuana was the most widely used drug globally in 2014, with around 183 million users. Such a large user base makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding legalization of the drug for medicinal use. The National Institute on Drug Abuse is still conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune disease, pain, inflammation, seizures, mental disorders, and substance abuse disorders. Regulatory compliance is a key factor that influences cost, quality, and safety of cannabis (marijuana) medicines, as well as the capacity for the manufacturers in the medical cannabis market to be responsive, scalable, and innovative.
Medicinal Cannabis Market Future Outlook
Potential medicinal cannabis markets other than the U.S., include Canada, Israel, Australia, and Spain. Mexico is also in process to consider the legalization of cannabis. Other countries are expected to consider legalization of the drug, once conclusive evidence regarding the safety and efficacy of cannabis are obtained through extensive research. According to Arcview Group—a cannabis industry investment and research firm—around 200 investors met companies to capitalize on lucrative opportunities from commercialization of medicinal cannabis. This implies that there is a huge potential in the medicinal cannabis industry and pharmaceutical and biotechnology companies need to focus on increasing awareness about the drug emerging economies.
About Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com
Posted by at No comments:
Labels: , ,

Colostomy Bags Market Size, Share and Forecast upto 2025

Colostomy is a surgical procedure in which an opening is formed by drawing the healthy end of the large intestine or colon by an incision in the anterior abdominal wall and then suturing and setting it into place. This helps the patient in better bowel motions through the stoma and collected in special disposable colostomy bag, which fits over the stoma and sticks to the skin. Colostomy can be permanent or temporary, as colostomy can be reversed by joining two ends together. Colostomy bags market is gaining traction due to increasing prevalence of diseases such as irritable bowel syndrome, multiple sclerosis, Crohn’s disease and cancer. Besides these colostomy can be performed due to birth defects or accidental injury. The broad spectrum regarding the causes for the disease is expected to favor the growth in colostomy bags market in the near future.
Colostomy bags market is backed by some of the factors as they does not bring significant changes in lifestyle as most of the people are allowed to follow the diet as earlier and perform their daily routine after the surgery. Furthermore, to avoid infections around colostomy bag due to spillage of stool, sweating, dislocation of colostomy bags wide range of accessories are provided, which includes support belts, girdles, deodorizers, skin protective wipes and stoma paste. Moreover, there are different types of colostomy bags such as closed bags, drainable bags, one piece system and two-piece system that are designed according to patients need.
Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/503
Colostomy bags market taxonomy
By Product Type
  • Closed Pouch
  • Drainable Pouch
  • Two-Piece System
  • One-Piece System
By End Users
  • Hospital
  • Ambulatory Surgical Centers
  • Homecare Settings
Rise in incidence of Crohn’s disease and bowel cancer is expected to fuel the growth of colostomy bags market in the near future
Crohn’s disease is a type of inflammatory bowel disease (IBD) which can affect any part of gastrointestinal tract from mouth to anus which increase the market of colostomy bags. According to Centers for Disease Control and Prevention (CDC), 1.0-1.3 million people suffer from inflammatory bowel disease (IBD) as Crohn’s disease is more common in smokers. Whereas each year in the U.S. around 54,000 men and 17,000 women get bladder cancer according to Centers for Disease Control and Prevention (CDC), which significantly supports the rise in growth percentage of colostomy bags industry. The statistics provided above are expected to be a set of crucial factors that supports the growth in colostomy bags market over the forecast period.
Regional growth engines of the colostomy bags market
On the basis of regional segmentation, the global colostomy bags market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The global market is projected to show growth expansion in Asia Pacific due to the rise in incidence of colorectal cancer, increase in aging population and increase in medical tourism. According to Centers for Disease Control and Prevention (CDC) report in 2014, the highest incidence of colorectal cancer was reported in Asia Pacific and Hispanic with approximately 35 people out of 100,000 in 2013.
The key players dominating the global colostomy bags market
Providers in the market offer a broad range of colostomy bags and accessories and in increase in adoption of market strategies such as online marketing due to advanced technology to manufactures innovation in product competition in market is increasing. The key players operating the market of colostomy bag includes, Coloplast, ConvaTec, TG Eakin Hollister, Marlen, B. Braun Oakmed, and Welland Medical.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702



Posted by at No comments:
Labels: , , , ,

Sunday 23 July 2017

Extracorporeal Shock Wave Lithotripsy Market Size , Share and Forecast upto 2025

Extracorporeal shock wave lithotripsy is a non-invasive treatment for kidney stone and biliary calculi, using an acoustic pulse and are also used for salivary stones and pancreatic stones. The lithotripter supplies a high intensity acoustic pulse to crush the stone causing minimal collateral damage to the normal tissue and the shock waves break the stones into smaller portion. Extracorporeal shock wave lithotripsy are widely used by the physician globally due to its important characteristic such as non-invasiveness, recovery time, reduced pain and reduced hospital stay. Extracorporeal shock wave lithotripsy success rate is high for patients with smaller stones such as less than 1 centimeter. Also, rise in prevalence of obesity and increasing diabetic patient population also favors growth of the extracorporeal shock wave lithotripsy market.
Furthermore, rising incidence of kidney stones and ureter stones are expected to boost growth of the market in the near future. Rampant development of healthcare infrastructure in emerging economies and growing awareness about the availability of technically developed equipment to carry out the procedures favors growth of the market. After extracorporeal shock wave lithotripsy treatment, patient can resume daily activities within one to two days. According to the National Health and Nutrition Examination Survey held in 2012, prevalence of kidney stone was found to be higher in women than in males.
Extracorporeal Shock Wave Lithotripsy Market Taxonomy
By Technology
  • Electrohydraulic Technique
  • Electromagnetic Technique
  • Piezoelectric Technique
By Application
  • Kidney Stones
  • Uretic Stones
  • Pancreatic Stones
  • Salivary Stones
By End User
  • Hospital
  • Clinics
Extracorporeal shock wave lithotripsy market is being fuelled by rise in incidence of kidney stones
Extracorporeal shock wave lithotripsy is a valuable tool for eradication of stones from kidney, ureter, gallbladder, salivary gland, or salivary duct. Extracorporeal shock wave lithotripsy is used to find the stone and break it down into smaller fragments. Extracorporeal shock wave lithotripsy generates shockwaves, which are then focused onto the stone present in body with negligible diversion of energy that favors minimal damage to tissue. Extracorporeal shock wave lithotripsy is also most effective in treatment of non-obstructing renal calculi. Whereas the composition and density of stone decides the rate of shockwaves to be generated. According to Centers for Disease Control and Prevention, number of adults diagnosed by kidney disease are 4.9 million in the U.S. in 2015.
Furthermore, improvement in healthcare facilities, awareness regarding available technique promote the market of extracorporeal shock wave lithotripsy.
Growth engines for extracorporeal shock wave lithotripsy market
Most populated and urbanized regions such as North America, Asia-pacific and European region in the world that uses the advanced devices for treatment purpose shows the largest extracorporeal shock wave lithotripsy market. Europe also favors the growth of market due to increased government investment. The high growth in India and China can be attributed to government and venture capital investments in the field of extracorporeal shock wave lithotripsy to develop the market. Increase in incidence of kidney stone disease in the U.S. also favors the market of extracorporeal shock wave lithotripsy.
The key players dominating the global extracorporeal shock wave lithotripsy market
Investment in medical device technology and R&D have increased the competition among the manufacturers. Whereas manufacturers are focusing on offering advanced features to extracorporeal shock wave lithotripsy at affordable prices to gain a competitive edge in the market. The key players operating in the market are Boston Scientific Corporation, C.R. Bard Inc., Lumenis LTD, GE Healthcare and Siemens AG.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Posted by at No comments:
Labels: , ,

Animal Antimicrobials and Antibiotics Market Size, Share and Forecast upto 2025

Antibiotics are used for a variety of purposes in the husbandry of livestock, including therapeutic (treatment when ill), curing a batch of animals when a minimum of one among the group is diagnosed ill (metaphylaxis, it is similar to the method bacterial meningitis is managed in children), and prophylaxis or preventative treatment against a number of diseases. The employment of sub-therapeutic doses in water and/or animal feed to develop feed efficiency and encourage growth was eliminated altogether effective January 1, 2017, as per the new FDA Veterinary Feed Directive. Antimicrobials (including antifungals and antibiotics) and other types of drugs are used by livestock owners and veterinarians in the U.S. for control, treatment, or prevention of livestock diseases. Some of the countries outside North America and Europe can administer antimicrobials to augment the development rates of poultry, livestock, and other farmed animals, even though these drugs do not mandatorily have to be used by a veterinarian. The term animal antimicrobial or antibiotic is usually used for those agents who inhibit or kill the growth of microorganism in animals especially livestock.
Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/522
The rising demand for livestock products, owing to increasing population of livestock throughout the world is likely to boost growth of the animal antimicrobials and antibiotics market. Moreover, the rising incidence of diseases in livestock is likely to aid in the expansion of this market. However, the use of in-feed enzymes and stringent regulations are limiting the growth of this market. Another factor boosting the overall growth of the market is the growing demand for animal proteins and the increasing trend of pet ownership. The growing incidences of animal disease epidemics, rising population of livestock and favorable economic conditions of emerging economies including China, Brazil, and India, are encouraging the growth of this market.
On the other hand, some factors including the augmented administration of in-feed enzymes, firm regulatory policies in the field and increased use of substitute medicines including prebiotics are likely to restrain the growth of the overall animal antimicrobials and antibiotics market during the forecast period.
Animal antimicrobials and antibiotics market Taxonomy
On the basis of type of product,
  • Penicillin
  • Tetracycline
  • Sulfonamides
  • Quinolones
  • Macrolides
  • Cephalosporin
  • Amingoglycoside
  • Others
On the basis of type of animals,
  • Companion animals
  • Food-producing animals
On the basis of mode of delivery,
  • Oral powder or solutions
  • Injections
  • Premix
  • Others
High growth of livestock and increased consumption of milk and other food products will drive the overall animal antimicrobials and antibiotics market
The antimicrobial and antibiotic products have considerable benefits to the animal as well as to human food safety. Researchers have shown that a rise in the rate of animal illness invariably results into higher rate of illness among humans. Hence, livestock traders depend primarily on animal antibiotics to offer safe food. Another factor driving the market is the rising demand for meat, milk, and other animal food products. The profound usage of various types of meats and a variety of milk in the dairy products, especially in the western diet and the speedy adoption of these eating habits across the globe are expected to lead to a rise in demand for animal antimicrobials and antibiotics around the globe. These factors will fuel the growth of the animal antimicrobials and antibiotics market in the near future.
On the basis of geography, North America held the largest share of the animal antibiotics and antimicrobials market. This dominance can be attributed to the developed animal healthcare market in this region. Other factors driving the market in this region are growing demand for animal-derivative food products, increasing expenditure on animal healthcare, rising animal population, and increase in awareness about the zoonotic diseases (disease transmitted from animals to humans). Nonetheless, the Asia-Pacific market is likely to grow at the maximum CAGR, due to rising animal population, growing demand for animal based food products, rise in awareness about animal welfare and animal health, especially in the emerging economies of China and India.
The key market players operating in the global animal antimicrobials and antibiotics market are Merck & Co., Inc., Zoetis, Inc., Bayer AG, Virbac, Eli Lilly Company, Boehringer Ingelheim GmbH, Vetoquinol S.A., Ceva Sante Animale, Dechra Pharmaceuticals PLC and Sanofi.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Friday 21 July 2017

Bariatric Surgery Devices Market Size,Share and forecast upto 2025

Bariatric surgery, also known as weight loss surgery, is a class of bariatrics, which refers to a minimally- invasive surgical procedure performed on people suffering from obesity. Bariatric surgery aims to reduce the weight of an individual with the help of a surgery that reduces the size of stomach by removing a portion of tissues or fats of the stomach. The National Institutes of Health in the U.S. suggests a person to undergo bariatric surgery depending on the BMI of the individual. Bariatric surgery is recommended to individuals with a minimum BMI of 40 whereas, people with specific serious coexisting medical conditions such as diabetes can also undergo bariatric surgery with a BMI of 35.
According to World Health Organization, the worldwide obesity has more than doubled since 1980. The key facts suggests that in 2014, over 1.9 billion adults were reported to be overweight, out of which 600 million were reported obese. This trend was observed to persist even in children under the age group of 5 years, wherein 41 million children were found to be overweight. This has predominantly increased the rates at which people are undergoing bariatric surgery, thereby elevating the bariatric surgery devices market. In addition to this, precaution and preventive measures undertaken by people has resulted in rise of overall expenditure on weight loss which in turn promotes the global sales of bariatric surgery devices. Moreover, the regional governments taking initiatives regarding weight assessment and obesity related issues are also positively influencing the bariatric surgery devices market.
Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/429
Adjustable gastric bands to capture highest sales in the bariatric surgery devices market
Based on the devices, the market can be segmented as:
  1. Adjustable gastric bands
  2. Intra- gastric balloons
  3. Implantable gastric stimulators
  4. Gastric surgery clamps
  5. Surgical staples
  6. Others (Clip appliers, Endo stitch, Trocars)
On the basis surgery, the market can be segmented as:
  1. Adjustable gastric bands (AGB)
  2. Vertical sleeve gastrectomy (VSG)
  3. Roux-en-Y Gastric Bypass (RYGB)
  4. Biliopancreatic Diversion with duodenal switch (BPD- DS)
North America to contribute a highest share in the bariatric surgery devices market
North America was reported to be the largest regional contributor to the bariatric surgery devices market in 2014, followed by the Europe. This is mainly attributed to high rates of obesity in the U.S. and active government involvement and support to expand research in the field that is undertaken by various companies manufacturing bariatric surgery devices. For instance, the German federal ministry has formed a funded research program called as the Competence Network Obesity and Integrated Research at about USD 26 Million for the years 2012-2015. Government initiatives such as accessibility to the patient population and distribution of early care strategies and community guide in order to control and treat obesity in the American and the European countries are playing a pivotal role in the growth of bariatric surgery devices market. On the other hand, Asia Pacific is the fastest growing potential market for bariatric surgery devices. This is mainly due to rapidly increasing inclination of the populace towards fast food, in turn increasing prevalence of obesity. The market in the region is also characterized by the wide availability of low cost devices. Moreover, major players in the market are focusing closing studying consumer behavior and accordingly aligning their strategies to best capitalize on opportunities on offer. For example, Covidien Plc set up a research facility in India to find out the factors responsible for obesity in India.
High obesity rates in the world regulating the growth for bariatric surgery devices market
The major factor driving the bariatric surgery device market is the rapid growth of obesity cases across the globe. The Institute of Health Metrics and Evaluation suggests that 2.1 billion people, which accounts up to 30% of the world population are suffering with obesity and overweight. Thus, the awareness in these population can be potential to fuel the demand of these surgical devices. Additionally, a major shift in food habits, fast food preferences, imbalanced diet and inclination of majority of population towards luxuries and sedentary lifestyles are major factors leading to obesity that can boost the bariatric surgery devices industry growth. The medical practitioners and surgeons that are improving their skills to meet the rising demand for bariatric surgery are also responsible for impacting the market growth. Moreover, the non- invasive nature of this surgical technique that causes no apprehension to the patients makes it more viable and feasible thereby resulting in the expansion of the market at faster rates. However, certain restrains such as chances of internal bleeding, gastric band slippage, hernias, bowel obstruction and gastrointestinal ulcers can prove to barriers of the bariatric surgery devices market.
Allergen, Covidien, Ethicon, Olympus, Medtronic Inc. collaboratively dominating the bariatric surgery devices market
The major players in this market are Allergan Inc., Cousin Biotech, Covidien PLC, Endogastric Solutions Inc., EntroMedics Inc, GI Dynamics Inc, Intuitive Surgical Inc., Johnson and Johnson, Olympus, Pare Surgical, ReShape Medical, Inc., Spatz FGIA Inc., Transenterix, Inc. Allergen, Covidien, Ethicon, Olympus, Medtronic Inc. are the market leaders. Devices for sleeve gastrectomy launched by Medtronic has indicated expansion of the bariatric surgery devices market. The regional governments are also involved in assisting the manufacturers by providing the companies with a certain capital that can be useful for market expansion.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Fetal Monitoring Market Size, Share and forecast upto 2025

Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe and healthy. These are also used to monitor chronic mental retardation, hypothermia, lung diseases, neonatal diseases, vision & hearing problems, and jaundice. Fetal monitoring is usually done using handheld doppler device or an electronic fetal monitor. Fetal monitoring is necessary to avoid complications during labor or if patient gets an epidural or if oxytocin is required to induce or augment labor.  Moreover there are two ways to perform fetal monitoring namely, external and internal. Fetal monitoring is especially helpful if the patient is expected to have a high-risk pregnancy, especially women suffering from high blood pressure or diabetes.
Furthermore, the devices are used to check if pre-tern labor medicines are affecting the baby. Fetal monitoring devices are also used in other tests, which includes contraction stress test, non-stress test and biophysical profile that includes the combination of non-stress test and ultrasound. Uterine contractions or pushing during the second stage of labor also affects heart rate of the fetus and thus, fetal monitoring devices play a vital role through the process..
Fetal monitoring market taxonomy
By product type
  • Ultrasound
  • 2D Ultrasound
  • 3D & 4D Ultrasound
  • Doppler Imaging
  • Intrauterine Pressure Catheter (IUPC)
  • Telemetry Solutions
  • Electronic Fetal Monitoring (EFM)
  • External EFM
  • Internal EFM
  • Fetal Electrodes
  • Fetal Doppler
By Methods,
  • Invasive
  • Non-Invasive
By Applications,
  • Antepartum Fetal Monitors
  • Intrapartum Fetal Monitors
By Portability,
  • Portable
  • Non-Portable
By End Users
  • Hospitals
  • Clinics
Increase in birth rate fuels the growth of fetal monitoring market
The boost in fetal monitoring market is due to increased rate of birth and pre-tern births. Various government and nongovernment organizations are actively taking initiatives to provide better maternal and fetal care. However, rise in number of problems during pregnancy due to high-blood pressure, diabetes, pre-tern labor medicine affect the fetus. So, fetal monitoring device are used routinely by gynecology and obstetrics interventions to examine fetal health during labor and delivery. Furthermore, advancement in technology such as wireless or real time analysis also expands the market of fetal monitoring devices. The demand of fetal monitoring device is also increased significantly in past few years to reduce intrapartum stillbirths. According to WHO, annually 15 million babies are born pre-tern which leads to death. Pre-tern babies live only till approx. 5 years of age which is also responsible for nearly 1 million deaths in 2015.
Regional growth engines for fetal monitoring market
Asia Pacific is an emerging region for fetal monitoring market, as healthcare awareness is on the rise in the region and the region is the most populous. However, according to stats mention in World Population Prospects: 2015 Revision, the total fertility was pegged at 2.5 children per woman globally. However, there is wide regional difference across the globe that is further expected to offer irregular scenario over the forecast period in fetal monitoring industry. Furthermore, Africa shows the highest fertility at 4.7 children per women. Whereas Europe has the lowest fertility of 1.6 children per women. Both Asia and Latin America and Caribbean have total fertility of 2.2 children per women which can boost the fetal monitoring market.
Major acquisitions to support growth of fetal monitoring market
Rise in support from government for enhanced maternal facilities such as subsidies given by government to expand care in rural area to private not-for-profit organization, in countries like Uganda as they have poor healthcare facilities. Whereas, the Government of the Philippines has also placed health and maternal health high on its political agenda of reform. Moreover, rising investment of company for development of new features for fetal monitoring devices expects to increase the working efficiency of company and broadens its product portfolio. Key players in the fetal monitoring market include ArjoHuntleigh, Inc. (U.S.), C FUJIFILM SonoSite, Inc. (U.S.), GE Healthcare (U.K.), Natus Medical Incorporated (U.S.), Neoventa Medical (Sweden), ovidien PLC (U.S.),Philips Healthcare (Netherlands), Siemens Healthcare (Germany), Analogic Corporation (U.S.), and Spacelabs Healthcare Inc. (U.S.).
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Optical Imaging Market Size, Share and forecast upto 2025

Optical imaging is an emerging non-invasive technique used for capturing images of the internal parts of the body. Visible light and photons are incorporated to take the complete image of internal organs and tissues, the images of smaller structures are also taken, which include cells and molecules. Optical imaging uses the properties of photons such absorption and scattering, the spectra of light measures and perceives the properties of organs and soft tissues. Although, optical imaging technology is at its early phase of development, a wide range of technological advantages are offered over current imaging technologies. The images are referred by doctors for diagnosis and treatment of various diseases and by scientists for carrying out diverse research work. Optical imaging has proved to be much harmless and efficient compared to MRI and X-ray that use ionizing radiation for imaging.
Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/439
The non-invasive technology and increasing prevalence is expected to boost the growth of optical imaging market
According to the World Health Organization in 2012, population above 65 years has grown the highest and is expected to rise from 13% in 2010 to 53% by 2020. The key factors contributing to the growth of the optical imaging market are high prevalence of neurological and ophthalmologic disorders, increase in R&D activities in the life sciences sector, preclinical research, rising demand for radiation free imaging modalities in drug discovery processes. Moreover, the provision to acquire in-depth images of complex components of eyes, surface tissues, membranes vascular systems and gastrointestinal tract are driving the growth of the global market. Furthermore, vast application scope of the advance optical imaging products, operator and patient safety and comfort are other factors driving the growth. The emerging state of optical imaging market is also due to the use of non-ionizing radiations that reduce the harmful radiation exposure of patients.
Scanning laser microscopes used to identify cancer without painful biopsies and is expected to drive the global optical imaging market
The global optical imaging market is segmented on the basis of product type, therapeutic area, application, end user and geography.
On the basis of product type,
  • Imaging systems
  • Optical Imaging Systems
  • Spectral Imaging Systems
  • Software
  • Lenses
  • Illumination systems
  • Cameras
  • Others
On the basis of therapeutic area,
  • Neurology
  • Oncology
  • Dentistry
  • Dermatology
  • Ophthalmology
  • Cardiology
  • Others
On the basis of applications,
  • Pre-clinical and clinical research
  • Intra-operative Imaging
  • Pathological imaging
On the basis of end user,
  • Diagnostic Imaging Centers
  • Hospitals
  • Research Laboratories
Development in healthcare infrastructure and rising prevalence of chronic diseases is expected to dominate North American optical imaging market
Regional segmentation of the optical imaging market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East and Africa. According to the National Institute of Aging in 2015, 524 million people were aged 65 or older in 2010 and by 2050 it is estimated to nearly triple to about 1.5 billion, which will represent 16 percent of the world’s population. North America dominates the global optical imaging industry as the high usage of the optical imaging technologies in applications like oncology, dentistry and dermatology. It also comprises of huge geriatric population suffering from disorders that require optical imaging devices, which in turn will contribute towards the growth of optical imaging market. Key factors responsible for the rapid growth of Asia-Pacific market is the presence of high patient population suffering from various disorders along with high prevalence of chronic diseases. Increasing healthcare awareness, development of healthcare infrastructure, growing purchase power will fuel the growth of global optical imaging market.
Product launch, collaborations and acquisition by Abbott is expected to create high growth in optical imaging market
Key players operating in the optical imaging market are Abbott, Bioptigen Inc., Topcon Medical systems, Inc., Carl Zeiss Meditec AG with the strategies that include collaboration & merger, product launch. The acquisition of St Jude Medical in April 2016 by healthcare giant Abbott has created tremendous growth in neuromodulation, cardiovascular and atrial fibrillation market. Other market players include Heidelberg Engineering, Inc., Santec Corporation, Headwall Photonics, Inc., AGFA Healthcare, Headwall Photonics, Inc. and Optovue, Inc.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Thursday 20 July 2017

Hyperbaric Oxygen Therapy (HBOT) Devices Market size, share and forecast upto 2025

Hyperbaric oxygen therapy (HBOT) devices are used to deliver 100% pure oxygen to tissues in the body under high atmospheric pressure. During HBOT, the pressure is increased to three times the normal atmospheric pressure, creating high amount of partial pressure of oxygen. Under normal conditions, one atmosphere absolute are subjected to be around 14.7 pounds per square inch of pressure and the air we normally breathe is composed of 21% oxygen and 79% nitrogen. Breathing in 100% oxygen, the body is exposed to rise in atmospheric pressure, the oxygen molecules become condensed and this allows to breathe a higher amount of partial pressure of oxygen, where in turn oxygen dissolves in the plasma around 10 to 15 times greater than normal. This super-saturation of oxygen in the body’s tissues promotes the increase in capillary growth, increase in white blood cell (WBC) activity, new tissues development, increase oxygen tension in hypoxic areas, reduction in the size of gas bubbles and numerous other physiological effects.
HBOT devices play a vital role in the field of medicine, these devices help in the treatment of many diseases such as asthma, HIV/AIDS, bell’s palsy, Parkinson’s disease, spinal cord injuries, hepatitis, migraines, multiple sclerosis, stroke and sport injuries. Moreover, HBOT devices have Food and Drug Administration (FDA) approval for treating decompression sickness, thermal, necrotizing soft tissues infection and burn injury. HBOT devices are also used in the off-label (means the medication is not specified in the FDA's approved packaging label) medical induction treatment such as brain injuries and cancer. Such high preference from the patients and physicians for HBOT in medical field has powered growth in the HBOT devices market. The market is expected to rise in the forecast period, especially across the North America, Europe and Asia-Pacific region.
Hyperbaric oxygen therapy (HBOT) devices market by taxonomy
Hyperbaric Oxygen Therapy Devices Market, by Product Type:
  • Monoplace HBOT Devices
  • Topical HBOT Devices
  • Multiplace HBOT Devices
by Application:
  • Wound Healing
  • Decompression Sickness
  • Infection Treatment
  • Gas Embolism
  • Others
by Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
Increase in number of wound healing treatment and cosmetic procedures is expected to support the growth of hyperbaric oxygen devices market
The growth in usage of hyperbaric oxygen therapy in healing of wound and cosmetic procedure is one of the factor to rise in demand in forecast period and also the rise in healthcare costs, increase in prevalence of diseases such as asthma, diabetes, and growth rate in aging population are some of the factors that can be accounted for the largest market share. Asia Pacific market is expected to grow in the forecast period due to the increase in income, growth in medical tourism industry, and rise in public awareness benefits HBOT devices.
People who are suffering from diabetes are at increased risk for a wound development. According to the Center for Disease Control and Prevention (CDC) in the U.S., it was diagnosed that around 21.0 million people suffered from diabetes in 2014. The U.S. is expected to be the growth engine of the global HBOT market through the forecast period. This is mainly attributed to increase in incidence rate of diabetes, and rising chronic disease and acute wounds and simultaneously growth in treatment rate due to the developed healthcare technology, healthcare expenditure by the government and high disposable income are some of the factors that are expected to support the market in future near.
As per The American Society of Plastic Surgeons (ASPS) around 15.9 million minimally invasive cosmetic procedures were performed in 2014-2015 in the U.S. Moreover, increasing number of metrosexual men is in turn expected to create a highly conducive environment for growth of the HBOT market.
Key players in the market:
  • Fink Engineering
  • HAUX-LIFE-SUPPORT
  • Gulf Coast Hyperbarics, Inc.
  • IHC Hytech B.V. (Royal IHC)
  • HEARMEC; Hyperbaric
  • Sechrist Industries, Inc.
  • OxyHeal International
  • Haux-Life-Support GmbH
  • HYPERBARIC S.A.C.
  • Hyperbaric Technology (HyTech) B.V.
  • Sands Hyperbaric Corporation
  • SOS Medical Group Ltd.
  • Hearmec Co., Ltd. and Fink Engineering Pty. Ltd.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Global In vitro diagnostics (IVD) market is expected to expand at a CAGR of 4.3% during the period 2016 – 2024.

The Global In Vitro Diagnostics (IVD) Market was valued at US$ 19,635.8 million in 2015 and is projected to expand at a CAGR of 4.3% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Increasing number of applications in chronic cancer and other chronic diseases is projected to support growth of the In vitro diagnostics (IVD) market over the forecast period.
In vitro diagnostics (IVDs) are currently an important part of the healthcare sector. IVD devices and services are used in diagnosing, monitoring, and screening in various chronic and acute disorders. This further contributes to the availability of medical information related to the patient. Due to specificity of treatments, IVDs is expected to minimize the stay of the patients in hospitals and convalescences, which results in healthier population and cost effective treatment that favors economic growth in the long run. IVD plays an important role in the global healthcare industry as it is the initial point of any treatment for getting information regarding the ailments. The IVD market is projected to witness rapid growth fueled by advancements in various diagnosing and medical devices technologies with developed tools in diagnostics, early detection of the disease along with rise in availability of over-the-counter tests. Due to the application of IVDs in medical care it adds a significant value in the planned treatment processes enhancing better health results. Furthermore, in vitro diagnostics are the sequences of tests that are able to detect diseases symptoms through which physician can conclude the type of treatment to be given to the patient in very short period of time depending upon the quality of medical. There are various government guidelines to regulate the type of in vitro diagnostic tests. According to the FDA, the in vitro diagnostic devices are regulated through the Medical Device Amendments of 1976, which further divides the in vitro diagnostic products into three class such as class I, II and III that includes the products depending upon the level of regulatory control that can assure the safety and effectiveness.
To know the latest trends and insights prevalent in the In vitro diagnostics (IVD) market, click the link below:
Clinical chemistry product type segment in the in vitro diagnostic products market was the largest segment with significant contribution as compared to all the segments. There are various factors that affects the growth of the products in in vitro diagnostic market such as high unmet healthcare needs in categories of infectious disease, chronic disease and other acute allergies furthermore, increase in prevalence of cancer along with growth in demand for lab automation is expected to support the in vitro diagnostic market significantly in the near future. In 2015, according to the National Cancer Institute, majority of share in the type of cancer was contributed by lung and bronchus cancer, followed by colon, rectum and other type of cancers. Furthermore, in 2015, around 1.7 million new cases of cancer were expected to be diagnosed in the U.S., which further marked the source for rise in diagnostic tests globally.
Companies involved in the in vitro diagnostics devices manufacturing are highly active in expanding their product portfolio on the back drop of rise in number of applications of the IVD in healthcare sector. This is expected to provide wide choices to the physicians to choose for the appropriate type of test in particular symptoms, which is further expected to favor the growth of IVD market growth in the near future. Furthermore, acquisitions in the IVD market are frequent as compared to other sectors. Factor that encourage this trend include companies focusing on introducing new technologies, entry into new business segment and geographical expansion. The IVD market is undergoing a trend of strategic mergers and acquisitions, with market players focusing on enhancing their market presence. In 2015, Roche acquired Signature Diagnostics AG – based in Potsdam, Germany – this is expected further to strengthen the company’s next generation sequencing (NGS) diagnostic segment.
Key takeaways of the market:
  • The global In vitro diagnostics (IVD) market is expected to expand at a CAGR of 4.3% during the forecast period (2016–2024). Rising prevalence of chronic diseases across the globe is expected to favor the market for In vitro diagnostics over the forecast period.
  • The clinical chemistry product type segment in the global In vitro diagnostics (IVD) market was estimated to be the largest in 2015 and is expected to dominate throughout the forecast period in terms of value. Increasing prevalence for infectious disease due to poor infrastructure in emerging economies is expected to favor the growth of In vitro diagnostics (IVD) market in the near future.
  • In terms of product type, the molecular diagnostics product type segment is expected to expand at a significant CAGR of 8.2% during the forecast period, owing to rise in rise in number of research institutes and demand for novel drugs in the market
  • The global In vitro diagnostics (IVD) market is characterized by strategic research and development and advancements in the technology of in vitro diagnostic services including the rise in various applications over the forecast period.
  • Some of the major players are Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Sysmex Corporation, Bio-Rad Laboratories, bioMérieux, Becton, Dickinson and Company and Danaher Corporation
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Posted by at No comments:
Labels: , ,
Subscribe to: Posts (Atom)